Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis (Q39446700)

12 September 2017

Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis (English)

1 reference

Stanislava Stosic-Grujicic

12 September 2017

0 references

0 references

series ordinal

2

1 reference

12 September 2017

Tamara Saksida

1

0 references

Stellan Sandler

series ordinal

4

object named as

Stellan Sandler

1 reference

12 September 2017

Gordana Timotijevic

3

1 reference

PubMed ID

22064706

12 September 2017

Ivana Stojanovic

series ordinal

5

1 reference

12 September 2017

8 November 2011

1 reference

Immunology & Cell Biology

12 September 2017

1 reference

12 September 2017

90

1 reference

12 September 2017

7

1 reference

12 September 2017

688-698

1 reference

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

12 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

The beta-cell in human type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic beta-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Inflammatory mechanisms in the regulation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Inflammatory process in type 2 diabetes: The role of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Macrophage migration inhibitory factor: a regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

The mif gene is transcriptionally regulated by glucose in insulin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Macrophage migration inhibitory factor induces cardiomyocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Tumor growth-promoting properties of macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Apoptosis: embedded in membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

21 January 2018

Bax activation by Bim?

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

The role of macrophage migration inhibitory factor in mouse islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Lipotoxicity in human pancreatic islets and the protective effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Palmitate-induced inhibition of insulin gene expression in rat islet β-cells involves the ceramide transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

Palmitate activates AMP-activated protein kinase and regulates insulin secretion from beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

inferred from DOI database lookup

7 January 2021

based on heuristic

Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.89

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ICB.2011.89

1 reference

12 September 2017

1 reference

PubMed ID

22064706